Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 298

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 298
---
 subject to the reporting requirements of Section 13 or 15(d) of the Exchange 
 Act;                                                                                                         |

| ● | the issuer of the securities has filed all Exchange Act reports and material required to be filed, as                                     
 applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials) other 
 than Form 8-K reports; and                                                                                                                |

| ● | at least one year has elapsed from the time that the issuer filed current Form 10-type information with 
 the SEC reflecting its status as an entity that is not a shell company.                                 |

We are no longer a shell company and, as a result, once the conditions set forth in the exceptions listed above are satisfied, Rule 144 will become available for the resale of shares of Common Stock. Registration Rights Each of the Investor Rights Agreement, the Keystone Registration Rights Agreements, the Arena Purchase Agreement, the Fee Modification Agreements and the Liquidated Damages Modification Agreement provides for certain registration rights. For additional information, see the subsections entitled “ Description of Securities-Registration Rights.” 171 PLAN OF DISTRIBUTION The Common Stock offered by this prospectus are being offered by the Selling Securityholder. The shares may be sold or distributed from time to time by the Selling Securityholder directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be changed. The sale of our Common Stock offered by this prospectus could be effected in one or more of the following methods:

| ● | ordinary brokers’ transactions; |

| ● | transactions involving cross or block trades; |

| ● | through brokers, dealers, or underwriters who may act solely as agents; |

| ● | “at the market” into an existing market for our Common Stock; |

| ● | in other ways not involving market makers or established business markets, including direct sales to purchasers 
 or sales effected through agents;                                                                               |

| ● | in privately negotiated transactions; or |

| ● | any combination of the foregoing. |

In order to comply with the securities laws of certain states, if applicable, the shares may be sold only through registered or licensed brokers or dealers. In addition, in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from the state’s registration or qualification requirement is